Review: could Cyclophosphamide cause Chest X-ray Abnormal?


Summary

Chest x-ray abnormal is found among people who take Cyclophosphamide, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Vincristine Sulfate, and have Acute lymphocytic leukaemia . We study 50,360 people who have side effects while taking Cyclophosphamide from FDA and social media. Among them, 53 have Chest x-ray abnormal. Find out below who they are, when they have Chest x-ray abnormal and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Cyclophosphamide

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in breast cancer. (latest outcomes from Cyclophosphamide 62,807 users)

Chest X-ray Abnormal

Chest x-ray abnormal has been reported by people with fever, nasopharyngitis, skin blushing/flushing, hyperkalemia, skin test positive (latest reports from 2,822 Chest x-ray abnormal patients).

On Sep, 08, 2016

50,360 people reported to have side effects when taking Cyclophosphamide.
Among them, 53 people (0.11%) have Chest X-ray Abnormal


Number of reports submitted per year:

Could Cyclophosphamide cause Chest x-ray abnormal?

Time on Cyclophosphamide when people have Chest X-ray Abnormal *:

  • < 1 month: 83.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 16.67 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Chest X-ray Abnormal when taking Cyclophosphamide *:

  • female: 50 %
  • male: 50 %

Age of people who have Chest X-ray Abnormal when taking Cyclophosphamide *:

  • 0-1: 10.53 %
  • 2-9: 2.63 %
  • 10-19: 2.63 %
  • 20-29: 0.0 %
  • 30-39: 7.89 %
  • 40-49: 5.26 %
  • 50-59: 18.42 %
  • 60+: 52.63 %

Top conditions involved for these people *:

  • Stem Cell Transplant (4 people, 7.55%)
  • Acute Lymphocytic Leukaemia (4 people, 7.55%)
  • Non-Hodgkin's Lymphoma (3 people, 5.66%)
  • Breast Cancer (3 people, 5.66%)
  • Bone Marrow Transplant (3 people, 5.66%)

Top co-used drugs for these people *:

  • Vincristine Sulfate (14 people, 26.42%)
  • Prednisone (10 people, 18.87%)
  • Doxorubicin Hcl (10 people, 18.87%)
  • Prednisolone (8 people, 15.09%)
  • Vincristine (7 people, 13.21%)

Top other side effects for these people *:

  • Pyrexia (15 people, 28.30%)
  • Dyspnoea (15 people, 28.30%)
  • Hypoxia (12 people, 22.64%)
  • Respiratory Failure (10 people, 18.87%)
  • Hypotension (10 people, 18.87%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Chest x-ray abnormal when taking Cyclophosphamide?


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.